Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.

Gauffin O, Brand JS, Vidlin SH, Sartori D, Asikainen S, Català M, Chalabi E, Dedman D, Danilovic A, Duarte-Salles T, García Morales MT, Hiltunen S, Jödicke AM, Lazarevic M, Mayer MA, Miladinovic J, Mitchell J, Pistillo A, Ramírez-Anguita JM, Reyes C, Rudolph A, Sandberg L, Savage R, Schuemie M, Spasic D, Trinh NTH, Veljkovic N, Vujovic A, de Wilde M, Zekarias A, Rijnbeek P, Ryan P, Prieto-Alhambra D, Norén GN

Open source

DOI
10.1007/s40264-023-01353-w
Published
2023 Dec
Container
Drug safety
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s40264-023-01353-w,
  title = {Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.},
  author = {Gauffin O and Brand JS and Vidlin SH and Sartori D and Asikainen S and Català M and Chalabi E and Dedman D and Danilovic A and Duarte-Salles T and García Morales MT and Hiltunen S and Jödicke AM and Lazarevic M and Mayer MA and Miladinovic J and Mitchell J and Pistillo A and Ramírez-Anguita JM and Reyes C and Rudolph A and Sandberg L and Savage R and Schuemie M and Spasic D and Trinh NTH and Veljkovic N and Vujovic A and de Wilde M and Zekarias A and Rijnbeek P and Ryan P and Prieto-Alhambra D and Norén GN},
  year = {2023},
  journal = {Drug safety},
  doi = {10.1007/s40264-023-01353-w},
  url = {https://doi.org/10.1007/s40264-023-01353-w}
}

RIS

TY  - JOUR
TI  - Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.
AU  - Gauffin O
AU  - Brand JS
AU  - Vidlin SH
AU  - Sartori D
AU  - Asikainen S
AU  - Català M
AU  - Chalabi E
AU  - Dedman D
AU  - Danilovic A
AU  - Duarte-Salles T
AU  - García Morales MT
AU  - Hiltunen S
AU  - Jödicke AM
AU  - Lazarevic M
AU  - Mayer MA
AU  - Miladinovic J
AU  - Mitchell J
AU  - Pistillo A
AU  - Ramírez-Anguita JM
AU  - Reyes C
AU  - Rudolph A
AU  - Sandberg L
AU  - Savage R
AU  - Schuemie M
AU  - Spasic D
AU  - Trinh NTH
AU  - Veljkovic N
AU  - Vujovic A
AU  - de Wilde M
AU  - Zekarias A
AU  - Rijnbeek P
AU  - Ryan P
AU  - Prieto-Alhambra D
AU  - Norén GN
PY  - 2023
JO  - Drug safety
DO  - 10.1007/s40264-023-01353-w
UR  - https://doi.org/10.1007/s40264-023-01353-w
ER  - 

APA

O, G., JS, B., SH, V., D, S., S, A., M, C., E, C., D, D., A, D., T, D., MT, G. M., S, H., AM, J., M, L., MA, M., J, M., J, M., A, P., JM, R., C, R., A, R., L, S., R, S., M, S., D, S., NTH, T., N, V., A, V., M, D. W., A, Z., P, R., P, R., D, P., & GN, N. (2023). Supporting Pharmacovigilance Signal Validation and Prioritization with Analyses of Routinely Collected Health Data: Lessons Learned from an EHDEN Network Study.. Drug safety. https://doi.org/10.1007/s40264-023-01353-w

Source records